Mefruside

Mefruside

Clinical data
Routes of administration	Oral
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 4-chloro-N-methyl-N-[(2-methyloxolan-2-yl)methyl]benzene-1,3-disulfonamide
CAS Number	7195-27-9
PubChem CID	4047
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C13H19ClN2O5S2
Molar mass	382.88 g/mol
3D model (JSmol)	Interactive image
SMILES CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N

WikiDoc Resources for Mefruside
Articles
Most recent articles on Mefruside Most cited articles on Mefruside Review articles on Mefruside Articles on Mefruside in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mefruside Images of Mefruside Photos of Mefruside Podcasts & MP3s on Mefruside Videos on Mefruside
Evidence Based Medicine
Cochrane Collaboration on Mefruside Bandolier on Mefruside TRIP on Mefruside
Clinical Trials
Ongoing Trials on Mefruside at Clinical Trials.gov Trial results on Mefruside Clinical Trials on Mefruside at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mefruside NICE Guidance on Mefruside NHS PRODIGY Guidance FDA on Mefruside CDC on Mefruside
Books
Books on Mefruside
News
Mefruside in the news Be alerted to news on Mefruside News trends on Mefruside
Commentary
Blogs on Mefruside
Definitions
Definitions of Mefruside
Patient Resources / Community
Patient resources on Mefruside Discussion groups on Mefruside Patient Handouts on Mefruside Directions to Hospitals Treating Mefruside Risk calculators and risk factors for Mefruside
Healthcare Provider Resources
Symptoms of Mefruside Causes & Risk Factors for Mefruside Diagnostic studies for Mefruside Treatment of Mefruside
Continuing Medical Education (CME)
CME Programs on Mefruside
International
Mefruside en Espanol Mefruside en Francais
Business
Mefruside in the Marketplace Patents on Mefruside
Experimental / Informatics
List of terms related to Mefruside

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.

It was developed by Bayer A.G. and is sold under the tradename Baycaron.